» Articles » PMID: 21603314

Role of Optical Spectroscopy Using Endogenous Contrasts in Clinical Cancer Diagnosis

Overview
Specialty Oncology
Date 2011 May 24
PMID 21603314
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Optical spectroscopy has been intensively studied for cancer management in the past two decades. This review paper first introduces the background of optical spectroscopy for cancer management, which includes the advantages of optical techniques compared to other established techniques, the principle of optical spectroscopy and the typical setup of instrumentation. Then the recent progress in optical spectroscopy for cancer diagnosis in the following organs is reviewed: the brain, breast, cervix, lung, stomach, colon, prostate and the skin. Reviewed papers were selected from the PubMed database with keywords combining the terms of individual optical spectroscopy techniques and cancers. The primary focus is on the in vivo applications of optical spectroscopy in clinical studies. Ex vivo studies are also included for some organs to highlight special applications or when there are few in vivo results in the literature. Practical considerations of applying optical spectroscopy in clinical settings such as the speed, cost, complexity of operation, accuracy and clinical value are discussed. A few commercially available clinical instruments that are based on optical spectroscopy techniques are presented. Finally several technical challenges and standard issues are discussed and firm conclusions are made.

Citing Articles

Ultra-Fast Portable and Wearable Sensing Design for Continuous and Wide-Spectrum Molecular Analysis and Diagnostics.

Maity A, Milyutin Y, Maidantchik V, Pollak Y, Broza Y, Omar R Adv Sci (Weinh). 2022; 9(34):e2203693.

PMID: 36266981 PMC: 9731699. DOI: 10.1002/advs.202203693.


Intraoperative imaging in pathology-assisted surgery.

Voskuil F, Vonk J, van der Vegt B, Kruijff S, Ntziachristos V, van der Zaag P Nat Biomed Eng. 2021; 6(5):503-514.

PMID: 34750537 DOI: 10.1038/s41551-021-00808-8.


A roadmap for the clinical implementation of optical-imaging biomarkers.

Waterhouse D, Fitzpatrick C, Pogue B, OConnor J, Bohndiek S Nat Biomed Eng. 2019; 3(5):339-353.

PMID: 31036890 DOI: 10.1038/s41551-019-0392-5.


Spectroscopic and Imaging Characteristics of Pigmented Non-Melanoma Skin Cancer and Melanoma in Patients with Skin Phototypes III and IV.

Arroyo-Camarena S, Dominguez-Cherit J, Lammoglia-Ordiales L, Fabila-Bustos D, Escobar-Pio A, Stolik S Oncol Ther. 2017; 4(2):315-331.

PMID: 28261658 PMC: 5315082. DOI: 10.1007/s40487-016-0036-9.


[Stone treatment tomorrow and the day after].

Miernik A, Hein S, Adams F, Halbritter J, Schoenthaler M Urologe A. 2016; 55(10):1309-1316.

PMID: 27620184 DOI: 10.1007/s00120-016-0227-x.


References
1.
Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg B . In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt. 2006; 11(4):044005. DOI: 10.1117/1.2337546. View

2.
Skala M, Riching K, Gendron-Fitzpatrick A, Eickhoff J, Eliceiri K, White J . In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. Proc Natl Acad Sci U S A. 2007; 104(49):19494-9. PMC: 2148317. DOI: 10.1073/pnas.0708425104. View

3.
Jacobs A, Kracht L, Gossmann A, Ruger M, Thomas A, Thiel A . Imaging in neurooncology. NeuroRx. 2005; 2(2):333-47. PMC: 1064995. DOI: 10.1602/neurorx.2.2.333. View

4.
Kim Y, Liu Y, Backman V . Coherent backscattering spectroscopy: a new technique for tissue diagnosis. Conf Proc IEEE Eng Med Biol Soc. 2007; 2004:5285-8. DOI: 10.1109/IEMBS.2004.1404476. View

5.
Zonios G, Dimou A, Bassukas I, Galaris D, Tsolakidis A, Kaxiras E . Melanin absorption spectroscopy: new method for noninvasive skin investigation and melanoma detection. J Biomed Opt. 2008; 13(1):014017. DOI: 10.1117/1.2844710. View